2-Bromo-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 98%, 100mg

tert-Butyl (8-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamido)octyl)carbamate, 98%, 1g

(2R,4R)-1-tert-Butyl 2-methyl 4-aminopyrrolidine-1,2-dicarboxylate hydrochloride, 95.0%, 100mg

Lámina de cobre 99,995+% 0,05 x 100 x 100 mm 1 ud.

5-Ethynylpyridin-2-amine, 95.0%, 1g

5-Fluoronicotinaldehyde, 95.0%, 10g

Recipiente de reacción ROTILABO®, 50 ml, 1 pieza

4,7,10,13-Tetraoxapentadecanoic acid, 15-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-, 2,5-dioxo-1-pyrrolidinyl ester, 97%, 100mg

Acetato de cobalto(II) tetrahidratado, mínimo 98 %, extrapuro, 100 g, envase de plástico.

4,4'-Sulfonylbis-morpholine, 5g

(1R,5S)-1-(4-Bromophenyl)-3-azabicyclo[3.1.0]hexane (hydrochloride), 1g

DABIGATRAN, 95%, 250mg

cis-4-Carbomethoxycyclohexane-1-carboxylic acid, 97.0%, 5g